Iron–sulfur cluster synthesis, iron homeostasis and oxidative stress in Friedreich ataxia
Open accessThe DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
Friedreich ataxia (FRDA) is an autosomal recessive, multi-systemic degenerative disease that results from reduced synthesis of the mitochondrial protein frataxin. Frataxin has been intensely studied since its deficiency was linked to FRDA in 1996. The defining properties of frataxin—(i) the ability to bind iron, (ii) the ability to interact with, and donate iron to, other iron-binding proteins, and (iii) the ability to oligomerize, store iron and control iron redox chemistry—have been extensively characterized with different frataxin orthologues and their interacting protein partners. This very large body of biochemical and structural data [reviewed in (Bencze et al., 2006)] supports equally extensive biological evidence that frataxin is critical for mitochondrial iron metabolism and overall cellular iron homeostasis and antioxidant protection [reviewed in (Wilson, 2006)]. However, the precise biological role of frataxin remains a matter of debate. Here, we review seminal and recent data that strongly link frataxin to the synthesis of iron-sulfur cluster cofactors (ISC), as well as controversial data that nevertheless link frataxin to additional iron-related processes. Finally, we discuss how defects in ISC synthesis could be a major (although likely not unique) contributor to the pathophysiology of FRDA via (i) loss of ISC-dependent enzymes, (ii) mitochondrial and cellular iron dysregulation, and (iii) enhanced iron-mediated oxidative stress.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Superoxide radical and superoxide dismutases
Fridovich, I. (1995) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.64.070195.000525 · Cited by 3,455
Friedreich's Ataxia: Autosomal Recessive Disease Caused by an Intronic GAA Triplet Repeat Expansion
Campuzano, V., Montermini, L., Moltò, M. D., Pianese, L., Cossée, M., Cavalcanti, F., Monros, E., Rodius, F., Duclos, F., Monticelli, A., et al. (1996) · Science · doi:10.1126/science.271.5254.1423 · Cited by 2,786 · cited 5×
“…Is a Multifunctional Component of ISC Synthesis Human frataxin (FXN) is initially synthesized in the cytoplasm as a precursor polypeptide (FXN1–210) (Campuzano et al., 1996) that is imported to the mitochondrial matrix and processed step-wise to shorter isoforms, FXN42–210, FXN56–210, FXN81–210,…”
BackgroundInfluentialStructure, function, and formation of biological iron-sulfur clusters
Johnson, D. C., Dean, D. R., Smith, A. D., & Johnson, M. K. (2005) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.74.082803.133518 · Cited by 1,438 · cited 1×
“DEFICIENT ISC SYNTHESIS AND THE PATHOPHYSIOLOGY OF FRDA ISC are essential and highly adaptable enzyme co-factors that can participate in a wide range of cellular reactions and processes [reviewed in (Johnson et al., 2005)].”
BackgroundFunction and biogenesis of iron-sulphur proteins
Lill, R. (2009) · Nature · doi:10.1038/nature08301 · Cited by 1,167
Aconitase and mitochondrial iron–sulphur protein deficiency in Friedreich ataxia
Rötig, A., de Lonlay, P., Chretien, D., Foury, F., Koenig, M., Sidi, D., Munnich, A., & Rustin, P. (1997) · Nature Genetics · doi:10.1038/ng1097-215 · Cited by 991
Puccio, H., Simon, D., Cossée, M., Criqui-Filipe, P., Tiziano, F., Melki, J., Hindelang, C., Matyas, R., Rustin, P., & Koenig, M. (2001) · Nature Genetics · doi:10.1038/84818 · Cited by 738 · cited 3×
“N IH -PA Author M anuscript N IH -PA Author M anuscript N IH -PA Author M anuscript accumulation (Puccio et al., 2001; Stehling et al., 2004).”
BackgroundFriedreich's ataxia: Pathology, pathogenesis, and molecular genetics
Koeppen, A. H. (2011) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2011.01.010 · Cited by 447
Selective iron chelation in Friedreich ataxia: biologic and clinical implications
Boddaert, N., Le Quan Sang, K. H., Rötig, A., Leroy-Willig, A., Gallet, S., Brunelle, F., Sidi, D., Thalabard, J.-C., Munnich, A., & Cabantchik, Z. I. (2007) · Blood · doi:10.1182/blood-2006-12-065433 · Cited by 409
Cossee, M. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.8.1219 · Cited by 377 · cited 1×
“Not surprisingly, a complete loss of mitochondrial ISC synthesis is incompatible with life (Cossee et al., 2000; Kispal et al., 2005; Lill and Kispal, 2000).”
BackgroundWong, A. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.3.425 · Cited by 374 · cited 8×
“…or partial loss of frataxin enhances sensitivity to oxidative stress in a wide variety of model systems including yeast (Santos et al., 2010), C. elegans (Vazquez-Manrique et al., 2006), Drosophila (Runko et al., 2008), mouse (Al-Mahdawi et al., 2006), and FRDA patient cells (Wong et al., 1999).”
BackgroundInfluentialJauslin, M. L., Meier, T., Smith, R. A. J., & Murphy, P. M. (2003) · The FASEB Journal · doi:10.1096/fj.03-0240fje · Cited by 358 · cited 2×
“This view is consistent with several observations that H2O2 detoxification (achieved via supplementation with selenium, reduced glutathione or glutathione peroxidase mimetics, or up-regulation of catalase) protects FRDA cells and Yfh1-depleted yeast from oxidant mediated damages (Jauslin et al., 2003; Jauslin et al.,…”
BackgroundIron-Dependent Self-Assembly of Recombinant Yeast Frataxin: Implications for Friedreich Ataxia
Adamec, J., Rusnak, F., Owen, W. G., Naylor, S., Benson, L. M., Gacy, A. M., & Isaya, G. (2000) · The American Journal of Human Genetics · doi:10.1086/303056 · Cited by 255 · cited 4×
“Although oligomeric yeast and human frataxin can be readily loaded with iron in the absence of other proteins in vitro (Adamec et al., 2000; Cavadini et al., 2002; Wang and Craig, 2008), it is unlikely that oligomeric frataxin would work like an iron chelator and scavenge iron indiscriminately in…”
BackgroundInfluentialSelf-citationRedox-Dependent Modulation of Aconitase Activity in Intact Mitochondria
Bulteau, A.-L., Ikeda-Saito, M., & Szweda, L. I. (2003) · Biochemistry · doi:10.1021/bi0353979 · Cited by 241
Iron use for haeme synthesis is under control of the yeast frataxin homologue (Yfh1)
Lesuisse, E. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg096 · Cited by 226
Friedreich ataxia: the oxidative stress paradox
Seznec, H., Simon, D., Bouton, C., Reutenauer, L., Hertzog, A., Golik, P., Procaccio, V., Patel, M., Drapier, J.-C., Koenig, M., et al. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi042 · Cited by 219 · cited 1×
“Similarly, superoxide dismutases are not upregulated in Yfh1-depleted yeast or in conditional frataxin knock-out mice (Chantrel-Groussard et al., 2001; Foury and Talibi, 2001; Seznec et al., 2005).”
BackgroundHuang, M. L.-H., Becker, E. M., Whitnall, M., Rahmanto, Y. S., Ponka, P., & Richardson, D. R. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0906784106 · Cited by 212
Chen, O. S., Crisp, R. J., Valachovic, M., Bard, M., Winge, D. R., & Kaplan, J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403209200 · Cited by 202 · cited 3×
“…increase in cellular iron uptake and a redistribution of iron within the cell, leading to mitochondrial iron accumulation and cytoplasmic iron depletion (Babcock et al., 1997; Chen et al., 2004; Knight et al., 1998; Li et al., 1999; Whitnall et al., 2008) [reviewed in (Rouault and Tong, 2005)].”
BackgroundGakh, O., Park, S., Liu, G., Macomber, L., Imlay, J. A., Ferreira, G. C., & Isaya, G. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddi461 · Cited by 184 · cited 2×
“It was later shown that mutations that inhibit Yfh1 oligomerization are asymptomatic only in unstressed cells, and otherwise enhance the sensitivity of yeast cells to oxidative stress, shortening chronological life span and causing lethality when combined with lack of copper-zinc superoxide dismutase (Gakh et al., 200…”
BackgroundSelf-citationIron–sulfur protein maturation in human cells: evidence for a function of frataxin
Stehling, O., Elsässer, H.-P., Brückel, B., Mühlenhoff, U., & Lill, R. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh324 · Cited by 176
Knight, S. A. B., Sepuri, N. B. V., Pain, D., & Dancis, A. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.29.18389 · Cited by 173 · cited 8×
“While the accumulated iron is progressively converted to an oxidized and insoluble or ferritin-bound form (Knight et al., 1998; Koeppen, 2011; Seguin et al., 2010), studies in yeast and human cells indicate that iron dysregulation is an early effect of frataxin depletion, which increases the fraction of labile redox-a…”
BackgroundInfluentialCampanella, A., Rovelli, E., Santambrogio, P., Cozzi, A., Taroni, F., & Levi, S. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn308 · Cited by 162
Seznec, H. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh114 · Cited by 138 · cited 1×
“In conditional knock-out mice with frataxin inactivation in cardiomyocytes or neurons, ISC-enzyme defects were detected prior to clinical symptoms, while oxidative stress markers were found only slightly increased or normal (Puccio et al., 2001; Seznec et al., 2004).”
BackgroundThierbach, R., Schulz, T. J., Isken, F., Voigt, A., Mietzner, B., Drewes, G., von Kleist-Retzow, J.-C., Wiesner, R. J., Magnuson, M. A., Puccio, H., et al. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi410 · Cited by 127 · cited 4×
“[Oxidative damage was documented in mice with conditional frataxin knock-out in pancreatic β cells or hepatocytes (Ristow et al., 2003; Thierbach et al., 2005), and mice with the GAA repeat expansion mutation (Al-Mahdawi et al.”
BackgroundInfluentialIron and iron-responsive proteins in the cardiomyopathy of Friedreich's ataxia
Michael, S., Petrocine, S. V., Qian, J., Lamarche, J. B., Knutson, M. D., Garrick, M. D., & Koeppen, A. H. (2006) · The Cerebellum · doi:10.1080/14734220600913246 · Cited by 122 · cited 4×
“Similarly, total iron content was not significantly higher in the left ventricle of FRDA patients compared to controls (Michael et al., 2006), however, iron deposits were observed inside FRDA cardiomyocytes (Koeppen, 2011; Lamarche et al., 1980; Michael et al., 2006) and electron-dense inclusions…”
BackgroundInfluentialIn vivo maturation of human frataxin
Condò, I., Ventura, N., Malisan, F., Rufini, A., Tomassini, B., & Testi, R. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm102 · Cited by 118 · cited 8×
“FXN42–210 and FXN81–210 are the most abundant isoforms both in normal individuals as well as FRDA carriers and patients (Condo et al., 2007; Gakh et al., 2010; Schmucker et al., 2008), and interestingly, they have strikingly different biochemical properties that have been characterized by…”
BackgroundInfluentialCampanella, A. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh232 · Cited by 109 · cited 2×
“Indeed, overexpression of mitochondrial ferritin, which is an avid iron chelator (Corsi et al., 2002), restored respiratory function in frataxin-depleted yeast (Campanella et al., 2004), HeLa cells (Zanella et al., 2008) and FRDA fibroblasts (Campanella et al., 2009).”
BackgroundAnderson, P. R., Kirby, K., Orr, W. C., Hilliker, A. J., & Phillips, J. P. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709691105 · Cited by 105
Reduction in frataxin causes progressive accumulation of mitochondrial damage
Karthikeyan, G. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg349 · Cited by 102
Karlberg, T., Schagerlöf, U., Gakh, O., Park, S., Ryde, U., Lindahl, M., Leath, K., Garman, E., Isaya, G., & Al-Karadaghi, S. (2006) · Structure · doi:10.1016/j.str.2006.08.010 · Cited by 85 · cited 3×
“, 2006)], and recently also with structural studies (Karlberg et al., 2006; Schagerlöf, 2008) (Fig.”
BackgroundSelf-citation
Cited by
Mechanisms of Mitochondrial Iron-Sulfur Protein Biogenesis
Lill, R., & Freibert, S.-A. (2020) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-013118-111540 · Cited by 453
An antioxidant nanozyme that uncovers the cytoprotective potential of vanadia nanowires
Vernekar, A. A., Sinha, D., Srivastava, S., Paramasivam, P. U., D’Silva, P., & Mugesh, G. (2014) · Nature Communications · doi:10.1038/ncomms6301 · Cited by 441
Friedreich Ataxia: Neuropathology Revised
Koeppen, A. H., & Mazurkiewicz, J. E. (2013) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31827e5762 · Cited by 261
Terzi, E. M., Sviderskiy, V. O., Alvarez, S. W., Whiten, G. C., & Possemato, R. (2021) · Science Advances · doi:10.1126/sciadv.abg4302 · Cited by 195
“9 of 11 form of inherited ataxia, a triple-repeat expansion mutation in the intron of the gene causes mis-splicing and low levels of FXN, an allosteric activator of ISC synthesis (13, 27).”
BackgroundCai, K., Tonelli, M., Frederick, R. O., & Markley, J. L. (2017) · Biochemistry · doi:10.1021/acs.biochem.6b00447 · Cited by 148
Metadata
- Authors
- Vaubel, R. A., & Isaya, G.
- Venue
- Molecular and Cellular Neuroscience
- Publisher
- Elsevier BV
- Published
- 2013-07
- Volume
- 55
- Pages
- 50-61
- ISSN
- 1044-7431 (ISSN-L)
- OpenAlex
- W2088038616
- Cited by
- 122
- References
- 29
- FWCI
- 4.86
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.